Caxton Associates (New York)’s Comerica CMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,403
Closed -$225K 542
2024
Q2
$225K Buy
+4,403
New +$225K 0.01% 432
2023
Q4
Sell
-15,485
Closed -$643K 473
2023
Q3
$643K Buy
+15,485
New +$734K 0.09% 211
2021
Q3
Sell
-13,758
Closed -$981K 467
2021
Q2
$981K Buy
+13,758
New +$1.02M 0.11% 74
2020
Q2
Sell
-36,694
Closed -$1.08M 482
2020
Q1
$1.08M Buy
+36,694
New +$1.99M 0.2% 56
2019
Q4
Sell
-15,018
Closed -$991K 412
2019
Q3
$991K Buy
15,018
+6,351
+73% +$420K 0.2% 42
2019
Q2
$630K Buy
8,667
+3,389
+64% +$252K 0.08% 150
2019
Q1
$387K Sell
5,278
-1,893
-26% -$152K 0.06% 189
2018
Q4
$493K Buy
7,171
+659
+10% +$52.4K 0.08% 122
2018
Q3
$587K Buy
+6,512
New +$621K 0.04% 211
2018
Q1
Sell
-125,000
Closed -$10.9M 343
2017
Q4
$10.9M Buy
+125,000
New +$10.1M 0.53% 55
2015
Q3
Sell
-22,550
Closed -$1.16M 85
2015
Q2
$1.16M Buy
+22,550
New +$1.1M 0.05% 113
2014
Q4
Sell
-65,000
Closed -$3.24M 127
2014
Q3
$3.24M Buy
+65,000
New +$3.26M 0.11% 124

Other funds holding CMA

Caxton Associates (New York)'s CMA Position: Q3 2024 in Review

Caxton Associates (New York) sold out of Comerica (CMA) in Q3 2024, closing a stake of 4,403 shares — an estimated $225K sold.

Caxton Associates (New York) first reported a position in CMA in Q3 2014 and held it in 12 quarters. The position peaked at $10.9M in Q4 2017. 530 funds tracked by Wall St. Rank hold CMA as of Q3 2024.

  • Caxton Associates (New York) reported no remaining Comerica position as of Q3 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 4,403 Comerica shares in Q3 2024, an estimated $225K.
  • Caxton Associates (New York) first reported a position in Comerica in Q3 2014 and held it in 12 quarters.
  • Caxton Associates (New York)'s Comerica position peaked at $10.9M in Q4 2017.
  • 530 funds tracked by Wall St. Rank held Comerica as of Q3 2024.

Based on Caxton Associates (New York)'s 13F filing for Q3 2024, filed 14 Nov 2024.